Overview

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month

Status:
Recruiting

Trial end date:
2023-01-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if one month of dual antiplatelet therapy (DAPT) combined with the placement of the Synergy® Stent with IVUS (intravascular ultrasound) is safe for patients who are at high risk of bleeding (HBR).

Phase:

Phase 2

Details

Lead Sponsor:

HonorHealth Research Institute

Collaborator:

Boston Scientific Corporation